Real‐world experience of 12‐week direct‐acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection
2019 ◽
Vol 35
(5)
◽
pp. 855-861
◽
2019 ◽
2019 ◽
2015 ◽
Vol 98
(4)
◽
pp. 394-402
◽
2017 ◽
2016 ◽
Vol 14
(12)
◽
pp. 1821-1830.e6
◽
2020 ◽
Vol 56
(1)
◽
pp. 105571
◽
2019 ◽
Vol 70
(1)
◽
pp. e113-e114
◽